Beijing Beilu Pharmaceutical Co., Ltd (SHE:300016)

China flag China · Delayed Price · Currency is CNY
9.44
-0.07 (-0.74%)
Aug 1, 2025, 2:45 PM CST
-0.74%
Market Cap5.11B
Revenue (ttm)1.06B
Net Income (ttm)16.66M
Shares Out541.64M
EPS (ttm)0.04
PE Ratio257.89
Forward PEn/a
Dividend0.05 (0.53%)
Ex-Dividend DateMay 19, 2025
Volume78,547,365
Average Volume53,625,388
Open8.92
Previous Close9.51
Day's Range8.92 - 9.83
52-Week Range4.38 - 10.97
Beta0.35
RSI57.63
Earnings DateAug 26, 2025

About SHE:300016

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as wel... [Read more]

Sector Healthcare
Founded 1992
Employees 1,173
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300016
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.